EARLY GLYCEMIC CONTROL REDUCES LARGE-FOR-GESTATIONAL-AGE INFANTS IN 250 JAPANESE GESTATIONAL DIABETES PREGNANCIES

ABSTRACT

Our objective was to test if tight glycemic control versus loose glycemic control in gestational diabetic patients and a gestational age of < 32 weeks influence fetal growth, fetal distress, and neonatal complication. We performed a retrospective study with 250 gestational diabetes mellitus in Japanese women. Two groups were categorized according to the timing at which good maternal glycemic control was attained at < 32 weeks and kept so until delivery (group 1) and > 32 weeks or never until delivery (group 2). In these two groups, neonatal growth (large-for-gestational age: LGA; appropriate- : AGA; and small- : SGA), neonatal complications (hypoglycemia, jaundice, polycythemia, and cumulative incidence), and incidence of fetal distress were compared. The χ² test, unpaired t test, one-way analysis of variance (ANOVA) and multiple logistic regression analyses were used for statistical analyses. Maternal age, height, prepregnancy body mass index (BMI), gestational age at delivery were not different between the groups. In group 2 (> 32 weeks), LGA, macrosomia (> 4 kg), neonatal hypoglycemia was significantly increased compared with those in group 1. Incidence of SGA, fetal distress, and neonatal jaundice were not different between the groups. Multiple logistic regression analysis for LGA showed significant relation to timing of maternal glycemic control. We concluded that good glycemic control should be attained at < 32 weeks and maintained until delivery to reduce LGA infants and neonatal hypoglycemia in gestational diabetes mellitus. This management did not appear to decrease SGA infants or fetal distress.

KEYWORD

Gestational diabetes mellitus - glycemic control - large-for-gestational age - neonatal complications

REFERENCES

• 1 Mimouni F, Tsang R C. Pregnancy outcome in insulin-dependent diabetes: temporal relationships with metabolic control during specific pregnancy periods.  Am J Perinatol . 1988;  5 334-338
• 2 Jovanovic L, Druzin M, Peterson C M. Effect of euglycemia on the outcome of pregnancy in insulin-dependent diabetic women as compared with normal control subjects.  Am J Med . 1981;  71 921-972
• 3 Metzger B E. Biphasic effects of maternal metabolism on fetal growth: quitessential expression of fuel-medicated teratogenesis.  Diabetes . 1991;  99-105 (99-105)
• 4 Sameshima H, Ikenoue T, Kawahara S, Kai M. Effects of longitudinal maternal glucose control on infants of diabetic mothers.  Acta Obstet Gynecol Japonica . 1991;  43 779-782
• 5 Lin C C, River J, River P, Blix P M, Munwad A H. Good diabetic control early in pregnancy and favorable fetal outcome.  Obstet Gynecol . 1986;  67 51-56
• 6 Metzger B E, Coustan D R, and the Organizing Committee. Summary and recommendations of the Fourth International Workshop Conference on Gestational Diabetes Mellitus.  Diabetes Care . 1998;  B161-B167 (B161-B167)
• 7 Berkowitz G S, Roman S H, Lapinski R H, Alvarez M. Maternal characteristics, neonatal outcome, and the time of diagnosis of gestational diabetes.  Am J Obstet Gynecol . 1992;  167 976-982
• 8 Sameshima H, Kamitomo M, Kajiya S, Kai M, Ikenoue T. Ketonemic tendency in gestational diabetic pregnancy in labor.  J Maternal Fetal Inv . 1996;  6 87-90
• 9 Langer O, Levy J, Brustman L, Anyaegbunam A, Merkatz R, Divon M. Glycemic control in gestational diabetes mellitus-how tight is tight enough: small for gestational age versus large for gestational age?.  Am J Obstet Gynecol . 1989;  161 646-653
• 10 Wechter D J, Kaufmann R C, Amankwah K S. Prevention of neonatal macrosomia in gestational diabetes by the use of intensive dietary therapy and home glucose monitoring.  Am J Perinat . 1991;  8 131-134
• 11 Obenshain S S, Adam P AJ, King K C. Human fetal insulin response to sustained maternal hyperglycemia.  N Engl J Med . 1970;  283 566-571
• 12 Sosenko I R, Kitzmiller J L, Loo S W, Blix P, Rubenstein A H, Gabbay K H. The infant of the diabetic mother: correlation of increased cord C-peptide levels with macrosomias and hypoglycemia.  N Engl J Med . 1979;  301 859-862
• 13 Sameshima H, Kamitomo M, Ibara S, Kajiya S, Kai M, Ikenoue T. Neonatal 24-hour urinary c-peptide and birth weight in infants of diabetic mothers.  J Maternal Fetal Med . 1999;  8 57-60
• 14 Lucas M J, Lowe T W, Bowe L, McIntire D D. Class A₁ gestational diabetes: a meaningful diagnosis?.  Obstet Gynecol . 1993;  82 260-265